31![EXECUTIVE SUMMARY The Prescription Drug User Fee Act (PDUFA) of 1992, as amended, requires the Food and Drug Administration (FDA or the agency) to report annually on the financial aspects of its implementation of the Act EXECUTIVE SUMMARY The Prescription Drug User Fee Act (PDUFA) of 1992, as amended, requires the Food and Drug Administration (FDA or the agency) to report annually on the financial aspects of its implementation of the Act](https://www.pdfsearch.io/img/51708bd3b60094280858585e77cc349e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
32![Microsoft Word - PDUFA FY 2011 clean[removed]doc Microsoft Word - PDUFA FY 2011 clean[removed]doc](https://www.pdfsearch.io/img/b5307eed2aa5d66de469795a57b87407.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
33![Food and Drug Administration Advisory Committee Member Acknowledgment of Financial Interests Food and Drug Administration Advisory Committee Member Acknowledgment of Financial Interests](https://www.pdfsearch.io/img/286a4c9b0cc9fdb7e4c555730bc700fe.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
34![PDMA DRAFT Q & A DOCUMENT PDMA DRAFT Q & A DOCUMENT](https://www.pdfsearch.io/img/5b979c70801e2b3d11da1255741b8a24.jpg) | Add to Reading ListSource URL: www.fda.gov.Language: English |
---|
35![Guidance for Industry Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act Guidance for Industry Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act](https://www.pdfsearch.io/img/90c1268ef9a6d290483805fae1480947.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
36![FDA Drug Review in PDUFA IV John K. Jenkins, MD Director, Office of New Drugs (CDER) 1 FDA Drug Review in PDUFA IV John K. Jenkins, MD Director, Office of New Drugs (CDER) 1](https://www.pdfsearch.io/img/bd94ccb813e1612b7df2419be55570c3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
37![Microsoft Word - Retrospective Review Final.doc Microsoft Word - Retrospective Review Final.doc](https://www.pdfsearch.io/img/f0a7bfe4c097aa43d61cc8302806fce1.jpg) | Add to Reading ListSource URL: www.fda.gov.Language: English |
---|
38![Responsiveness Summary for the Amendments to the Model Toxics Control Act Cleanup Regulation Chapter[removed]WAC Responsiveness Summary for the Amendments to the Model Toxics Control Act Cleanup Regulation Chapter[removed]WAC](https://www.pdfsearch.io/img/50872639f2ab4830d5783cbe75354fa8.jpg) | Add to Reading ListSource URL: www.ecy.wa.govLanguage: English - Date: 2008-05-12 13:23:20
|
---|
39![Clinical Trials Disclosure Henry Durivage, Pharm.D. Associate Director, Clinical Trials and Regulatory Affairs Yale Center for Clinical Investigation Clinical Trials Disclosure Henry Durivage, Pharm.D. Associate Director, Clinical Trials and Regulatory Affairs Yale Center for Clinical Investigation](https://www.pdfsearch.io/img/54faee73c50f91defcb20c8621098b0b.jpg) | Add to Reading ListSource URL: ycci.yale.eduLanguage: English - Date: 2014-11-11 08:53:57
|
---|
40![Drug Name Presentation Title Drug Name Presentation Title](https://www.pdfsearch.io/img/2063ab05a075f6df3195a9664ed9df6d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2008-03-31 14:45:54
|
---|